NATCO Pharma Q3 profit declines 37.75% to Rs 132.4 crore

NATCO Pharma Ltd connected Wednesday reported a 37.75 per cent diminution successful consolidated nett net to Rs 132.4 crore successful the December quarter, deed by a driblet successful formulations exports.

The institution had posted a consolidated nett net of Rs 212.7 crore successful the 3rd 4th of the erstwhile fiscal year, NATCO Pharma said successful a regulatory filing.

Consolidated gross from operations successful the 4th nether reappraisal stood astatine Rs 474.8 crore arsenic compared to Rs 758.6 crore successful the aforesaid play a twelvemonth ago, it added.

Total expenses successful the 3rd 4th were little astatine Rs 487.4 crore arsenic compared to Rs 539.3 crore successful the year-ago period, the institution said.

Formulation exports successful the 3rd 4th were little astatine Rs 285.8 crore arsenic compared to Rs 605.6 crore successful the aforesaid play of the past fiscal year. Formulation income successful the home marketplace stood astatine Rs 96.1 crore, down from Rs 99.4 crore successful the year-ago period, NATCO Pharma said successful an capitalist presentation.

On the different hand, API (active pharmaceutical ingredient) gross stood astatine Rs 66.6 crore, up from Rs 46.3 crore successful the corresponding 4th past fiscal year, it added.

The committee of directors astatine their gathering held connected Wednesday declared a 3rd interim dividend of Rs 1.50 each per equity stock of Rs 2 each for the fiscal twelvemonth 2024-25, the institution said.